We investigated the PGE 2 -pathway in human abdominal aortic aneurysm (AAA) and its relationship with hypervascularization. We analyzed samples from patients undergoing AAA repair in comparison with those from healthy multiorgan donors. Patients were stratified according to maximum aorta diameter: low (LD, <55 mm), moderate (MD, 
Introduction
Abdominal aortic aneurysm (AAA) is a late-age onset disorder that affects a high percentage of population in industrialized countries, and rupture of AAA is associated high mortality rates [1] . The etiology of AAA is complex with a relevant contribution of genetic factors [2] .
Although much effort has been made to clarify the mechanism of AAA development, currently the only effective approach to prevent aneurysm rupture is surgical repair by conventional or endovascular techniques.
Evidences have established a relationship between atherosclerosis and AAA, both disorders characterized by an underlying chronic inflammation. However, there are marked differences between atherosclerotic lesions and AAA. Whereas atherosclerotic plaque is characterized by leukocyte infiltration at the lumen site and hyperproliferation of vascular smooth muscle cells (VSMC) causing neointimal hyperplasia, AAA is characterized by leukocyte infiltration into adventitia and depletion of VSMC in the media. Other relevant features of AAA are the wall tension strength breakdown caused by proteolytic enzymes progressively destructing elastic fibers [3] and hypervascularization of aortic tissue. It has been proposed that this vascularization might contribute to the development and rupture of aneurysms [4, 5] .
Prostaglandin (PG) E 2 has been recognized as a relevant mediator in AAA. Biosynthesis of PGE 2 begins with the formation of PGH 2 , through the action of cyclooxygenase (COX) [6, 7] on arachidonic acid (AAc) released by phospholipases from the membrane phosphoglycerides. PGH 2 is then isomerized to PGE 2 by PGE-synthases (PGES). The microsomal isoform of PGES (mPGES-1) is inducible by proinflammatory cytokines and seems to be the main isoenzyme involved in PGE 2 biosynthesis under inflammatory conditions [8] [9] [10] [11] . COX-2/mPGES-1 is widely regarded as the major contributing enzymatic chain for PGE 2 biosynthesis under pathological conditions. COX-2-derived PGE 2 is involved by guest, on October 22, 2017 www.jlr.org Downloaded from in the pathogenesis of AAA as data from animal models and human studies indicate [12] [13] [14] [15] .
Furthermore, deletion of mPGES-1 attenuates experimental AAA in mice [16] . PGE 2 exerts its cellular effects by binding to four distinct E-prostanoid receptors (EP1-4) that belong to the family of seven transmembrane G protein-coupled receptors. Each receptor is involved in different and often opposite biological effects of PGE 2 . EP-2 and EP-4 are both Gs coupled receptors that upregulate intracellular cAMP levels, whereas EP-3 usually counteracts EP-2 and EP-4 mediated upregulation of cAMP by preferentially coupling to Gi proteins [17] . Recently, conflicting results have been reported on the role of EP-4 in AAA development in animal models [18] [19] [20] . These studies have been focused on the involvement of EPs in the activation of leukocytes (mainly macrophages) and VSMC and in the release of proteases during the immune-inflammatory process associated to AAA.
Main data regarding COX-2-alternative targets for the development of new anti-inflammatory drugs for AAA comes from studies in animal models [16, [18] [19] [20] . In these models, AAA develops fast and its etiology differs substantially from human pathology. Despite the role of PGE 2 in neovascularization in cancer and other pathologies and that the relevance of angiogenesis in AAA is widely accepted, information concerning COX-2/mPGES-1 derived PGE 2 in the AAA, particularly in AAA-associated hypervascularization, is limited and restricted to COX-2-derived PGE 2 from macrophages [12, 13, 21, 22] . Furthermore, the beneficial effects of COX-2 inhibitors and the deletion of mPGES-1 or EP-4 in experimental AAA is not fully understood in the context of this pathology in humans. Since PGE 2 modifiers have a possible therapeutic potential, the objective of the present study was to examine the elements involved in PGE 2 pathway in human AAA, particularly in microvasculature.
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Materials and Methods
Tissue samples. The study was approved by the Hospital de la Santa Creu i Sant Pau (HSCSP) Ethics Committee, and informed consent was obtained from each patient. All procedures were reviewed by the Institutional Review Board at HSCSP. The aorta biopsies were obtained from patients undergoing open repair for AAA at our institution. Samples were obtained from remaining mid-infrarenal aortic wall after exclusion and prosthetic replacement of AAA. Normal aortas were obtained from healthy aorta of multiorgan donors and samples were also taken from the mid-portion of the infrarenal abdominal aorta at the time of organ harvest. When Luminal thrombus was present in AAA samples it was separated before the aorta biopsy was taken and aortic tissue was washed twice with cold phosphate buffered saline (PBS). A portion of each sample was placed in RNAlater solution (Qiagen GmbH, Hilden, Germany) and stored at 4°C for 24 hours before long-term storage at −80°C until further processing for RNA isolation. Another portion was fixed in formalin solution 10%
(Sigma-Aldrich, Inc St Louis, MO) for 24 h and included in paraffin for immunohistochemical studies. Additional portions of aorta were placed in PBS to establish VSMC cultures and to obtain tissue secretomes.
Patients were stratified by the maximum transverse diameter defining three groups: low diameter (LD; <55 mm), moderate diameter (MD; 55-69.9 mm) and high diameter (HD, ≥70 mm). To determine the maximum aortic diameter, we use a transversal measurement to the true lumen center line at infrarenal level, based on Angio-CT with endovenous contrast, using Workstation AGFA IMPAX 6.4.0.4010 and OsiriX MD, FDA Cleared/CE IIa version, for primary diagnostic. Since surgical repair is not usually indicated in patients with AAA maximal diameter <55 mm, the aorta samples of the LD group were from patients with concomitant iliac artery aneurysm to be surgery repaired. according to the manufacturer's instructions. cDNA was prepared by reverse transcribing 1 µg RNA with High-Capacity cDNA Archive kit with random hexamers (Applied Biosystems, Foster City, CA). mRNA expression of the selected genes was studied by real-time PCR in an ABI Prism 7900HT using pre-designed validated assays (TaqMan Gene Expression Assays; Applied Biosystems, Foster City, CA) and universal thermal cycling parameters.
Relative expression was expressed as transcript/-actin ratios.
Analysis of PGE 2 .
To analyze plasma levels, a sample of 10 mL of peripheral blood was collected from all participants in heparin-containing tubes. In the case of AAA patients, blood was collected before anesthesia in the operating room. It was centrifuged immediately and plasma aliquoted and frozen at -80ºC until analysis. It is known that PGE 2 is rapidly transformed in vivo into 13,14-dihydro-15-oxo-PGE 2 that is unstable, and it undergoes a further transformation into 13,14-dihydro-15-oxo-PGA 2 [23, 24] . To evaluate plasma levels of PGE 2 we used an enzyme immunoassay (EIA) kit that converts 13,14-hihydro-15-oxo metabolites of PGE 2 into a single stable derivative (Cayman Chemical, Ann Arbor, MI) following manufacturer's instructions. Correlation method was then used. A "p" value below 0.05 was considered significant.
Results
Evaluation of hypervascularization and leukocyte infiltration in AAA samples. Table 1 summarizes the characteristics of patients and donors included in this study. We used vWF immunostaining to assess the distribution of microvessels in aortic samples. In normal aortas (NA) microvessels originated in the adventitia distributed regularly, traversed media and finished in the intima (many of them after bifurcation), but round microvessels in the media were scarce (Figure 1 ). Microvessels were abundant in the adventitia and in the media of AAA samples ( Figure 1 ) and the intima was often absent. While infiltrated leukocytes (determined by CD45 immunostaining) were scarce in NA, they were common in AAA.
Observation of 20 AAA samples revealed infiltrating leukocytes in the media in all of them.
Adventitia was also extensively vascularized with a concomitant accumulation of leukocytes.
Leukocyte infiltrate was systematically located in perivascular areas of microvessels ( Figure   1 ).
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We determined mRNA levels of two endothelial cell (EC) markers, vWF and endothelial nitric oxide synthase (eNOS) as an index of vascularization. In addition, we also analyzed expression levels of the VEGF-receptor-2 (VEGFR2) a gene highly expressed in EC.
Expression levels of these genes did not fit a normal distribution. Results in Figure 2A show that mRNA expression levels of the three genes were significantly enhanced in AAA. To further evaluate levels of these markers at different stages of AAA development we stratified AAA samples as a function of the maximum aorta diameter. Figure 2B shows the median of the EC marker expression for each AAA diameter group. We observed that expression of all three markers was maximal in the LD group and decreased thereafter. We also analyzed the expression levels of two leukocyte markers (undetectable in vascular cells in culture, data not shown): CD45 and five-lipoxygenase activating protein (FLAP). Additionally, we analyzed the expression of MMP-9, a metalloproteinase highly expressed by leukocytes. All of them were highly expressed in AAA samples ( Figure 2C ) and exhibited a maximum in the MD group ( Figure 2D ). Figure 3A show that the expression of COX isoenzymes and mPGES-1 was significantly higher in AAA than in NA samples. Immunohistochemistry showed that COX-2 expression was weak but ubiquitous in NA samples, mainly in adventitial microvessels and in medial VSMC ( Figure   3B ). In AAA samples we found COX-2 immunostained MVEC in the adventitia and media layers, VSMC in the media and also infiltrating leukocytes, inmunostaining being markedly increased in AAA ( Figure 3B ). Localization of mPGES-1 was similar to that of COX-2, NA and AAA displaying apparent similar immunostaining intensity ( Figure 3B ).
Expression of the enzymes involved in PGE 2 biosynthesis. Results in
In an attempt to approach the relative contribution of the endothelium to PGE 2 production in Figure 4A ). The characteristics of patients and controls included are shown in Table 1 . In figure 4A , we also show production of PGE 2 by NA and AAA samples after 48 h of incubation. AAA samples produced about 5-fold more PGE 2 than NA in terms of the median. In Figure 4B , transcript levels of COX-1, COX-2 and mPGES-1 are depicted as a function of AAA maximum diameter, showing that all of them displayed a maximum in the LD group.
Co-expression of EP-4 and mPGES-1 in aorta microvessels.
In human aorta samples, EP-1 was scarcely expressed and no significant differences were found between NA and AAA.
EP-2 and EP-4 were significantly increased in AAA while EP-3 was substantially decreased Both EP-4 and mPGES-1 were coexpressed in MVEC in culture ( Figure 7A ). Exogenously added PGE 2 and Cay10598 (a specific EP-4 receptor agonist) similarly induced angiogenesis, an effect that was abolished by the EP-4 antagonist AH23848 ( Figure 7B ). It is well known that IL-1 induces AAc mobilization in addition to COX-2 and mPGES-1 expression. Therefore, to explore whether the endogenous production of PGE 2 by MVEC promoted angiogenesis, we stimulated MVEC with human recombinant IL-1. IL-1β-induced angiogenesis was also suppressed by AH23848 ( Figure 7B ).
Discussion
This is the first study that analyzes the expression of the PGE 2 pathway as a whole in human AAA. The main objectives were: first, to investigate the expression of mPGES-1 in human AAA which has not been previously reported; second, to tentatively approach the contribution of microvascular endothelium to the bioavailability of PGE 2 in AAA; and third, to highlight the potential contribution of MVEC-derived PGE 2 , to the AAA-associated hypervascularization.
vWF immunostaining of aorta biopsies showed notable differences between NA and AAA.
NA was characterized by a regular distribution of microvessels that cross the vessel wall from the adventitia to the intima. In contrast, AAA exhibited many vessels parallel to the VSMC fibers in addition to adventitia-to-intima ones. The highest density of infiltrating ). Our results regarding localization of COX-2 showed that it was highly expressed in vascular cells and infiltrating leukocytes in AAA but weakly expressed in NA. These data strongly suggest that in AAA COX-2 was effectively up-regulated in vascular cells included MVEC. We found that, even significant, the increase of mPGES-1 expression in AAA was not as high as that of COX-2 (1.4-fold versus 4.3-fold, respectively). This suggests a dissimilar regulation of these two enzymes in AAA, as we previously described Since COX-2 and mPGES-1 were expressed in both, vascular cells and infiltrating cells, macrophages could also be a relevant source of PGE 2 in the AAA. Indeed, macrophage COX-2-derived PGE 2 has been found to be relevant in the pathogenesis and rupture of AAA [12, 13, 21, 22 ]. We can not rule out, however, the contribution of macrophage-associated COX-1 to the PGE 2 pool, since we found that COX-1 is increased in AAA probably due to recruited macrophages as mentioned above. In summary, we provide new evidence concerning the expression of mPGES-1 and the contribution that MVEC could have in the biosynthesis of PGE 2 in human AAA. Our data allow us to speculate that the COX-2/mPGES-1/EP-4 axis in MVEC is relevant for the PGE 2 -mediated hypervascularization of AAA, from the early stages of human AAA development.
Our data are also consistent with reports showing that suppression of either COX-2, mPGES-1 or EP-4 expression reduces AAA development in animal models [15, 16, 19, 20] , and reinforce the potential of mPGES-1 and EP-4 as alternative targets for therapy in AAA patients.
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